A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ENV-501 in Patients With HER3-Expressing Solid Tumors - Join Clinical Trial NCTNCT06956690
How to Join This Clinical Trial - NCTNCT06956690
Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1, PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06956690 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 6 locations. Find a study site near you:
Clinical Research Site
La Jolla, California 92093 - United States
Status: RECRUITING
Clinical Research Site
Indianapolis, Indiana 46250 - United States
Status: RECRUITING
Clinical Research Site
Farmington Hills, Michigan 48334 - United States
Status: RECRUITING
Clinical Research Site
Dallas, Texas 75230 - United States
Status: RECRUITING
Clinical Research Site
Campbelltown, New South Wales 2560 - Australia
Status: RECRUITING
Clinical Research Site
Miranda, New South Wales 2228 - Australia
Status: RECRUITING
How to Enroll in This Study
To learn more about participating in this PHASE1, PHASE2 clinical trial for Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships